Registro:

Referencias:

• Kang, C.B., Hong, Y., Dhe-Paganon, S., Yoon, H.S., FKBP family proteins: Immunophilins with versatile biological functions (2008) Neurosignals, 16 (4), pp. 318-325
• Li, H., Rao, A., Hogan, P.G., Interaction of calcineurin with substrates and targeting proteins (2011) Trends Cell Biol, 21 (2), pp. 91-103
• Callebaut, I., Renoir, J.M., Lebeau, M.C., An immunophilin that binds M(r) 90,000 heat shock protein: Main structural features of a mammalian p59 protein (1992) Proc. Natl Acad. Sci. USA, 89 (14), pp. 6270-6274
• Smith, D.F., Tetratricopeptide repeat cochaperones in steroid receptor complexes (2004) Cell Stress Chaperones, 9 (2), pp. 109-121
• Aviezer-Hagai, K., Skovorodnikova, J., Galigniana, M., Arabidopsis immunophilins ROF1 (AtFKBP62) and ROF2 (AtFKBP65) exhibit tissue specificity, are heat-stress induced, and bind HSP90 (2007) Plant Mol. Biol., 63 (2), pp. 237-255
• Sumanasekera, W.K., Tien, E.S., Turpey, R., Vanden Heuvel, J.P., Perdew, G.H., Evidence that peroxisome proliferator-activated receptor alpha is complexed with the 90 kDa heat shock protein and the hepatitis virus B X-associated protein 2 (2003) J. Biol. Chem., 278 (7), pp. 4467-4473
• Edlich, F., Lucke, C., From cell death to viral replication: The diverse functions of the membrane-associated FKBP38 (2011) Curr. Opin. Pharmacol., 11 (4), pp. 348-353
• Crackower, M.A., Kolas, N.K., Noguchi, J., Essential role of Fkbp6 in male fertility and homologous chromosome pairing in meiosis (2003) Science, 300 (5623), pp. 1291-1295
• Jarczowski, F., Jahreis, G., Erdmann, F., Schierhorn, A., Fischer, G., Edlich, F., FKBP36 is an inherent multifunctional glyceraldehyde- 3-phosphate dehydrogenase inhibitor (2009) J. Biol. Chem., 284 (2), pp. 766-773
• Lu, K.P., Zhou, X.Z., The prolyl isomerase PIN1: A pivotal new twist in phosphorylation signaling and disease (2007) Nat. Rev. Mol. Cell Biol., 8 (11), pp. 904-916
• Lee, T.H., Pastorino, L., Lu, K.P., Peptidyl-prolyl cis-trans isomerase Pin1 in ageing, cancer and Alzheimer disease (2011) Expert Rev. Mol. Med., 13, pp. e21
• Dong, L., Marakovits, J., Hou, X., Structure-based design of novel human Pin1 inhibitors (II (2010) Bioorg. Med. Chem. Lett., 20 (7), pp. 2210-2214
• Liu, C., Jin, J., Chen, L., Synthesis and biological evaluation of novel human Pin1 inhibitors with benzophenone skeleton (2012) Bioorg. Med. Chem., 20 (9), pp. 2992-2999
• Schiene-Fischer, C., Aumuller, T., Fischer, G., Peptide bond cis/trans isomerases: A biocatalysis perspective of conformational dynamics in proteins (2013) Curr. Top. Chem., 328, pp. 35-67
• Barik, S., Immunophilins: For the love of proteins (2006) Cell. Mol. Life Sci., 63 (24), pp. 2889-2900
• Gold, B.G., Villafranca, J.E., Neuroimmunophilin ligands: The development of novel neuroregenerative/ neuroprotective compounds (2003) Curr. Top. Med. Chem., 3 (12), pp. 1368-1375
• Quinta, H.R., Galigniana, M.D., The neuroregenerative mechanism mediated by the Hsp90-binding immunophilin FKBP52 resembles the early steps of neuronal differentiation (2012) Br. J. Pharmacol., 166 (2), pp. 637-649
• George, S., Pili, R., Carducci, M.A., Kim, J.J., Role of immunotherapy for renal cell cancer in 2011 (2011) J. Natl Compr. Canc. Netw., 9 (9), pp. 1011-1018
• Shi, Y., Serine/threonine phosphatases: Mechanism through structure (2009) Cell, 139 (3), pp. 468-484
• Das, A.K., Helps, N.R., Cohen, P.T., Barford, D., Crystal structure of the protein serine/ threonine phosphatase 2C at 2.0 A resolution (1996) EMBO J, 15 (24), pp. 6798-6809
• Chattopadhaya, S., Harikishore, A., Yoon, H.S., Role of FK506 binding proteins in neurodegenerative disorders (2011) Curr. Med. Chem., 18 (35), pp. 5380-5397
• Storer, C.L., Dickey, C.A., Galigniana, M.D., Rein, T., Cox, M.B., FKBP51 and FKBP52 in signaling and disease (2011) Trends Endocrinol. Metab., 22 (12), pp. 481-490
• Silverstein, A.M., Galigniana, M.D., Kanelakis, K.C., Radanyi, C., Renoir, J.M., Pratt, W.B., Different regions of the immunophilin FKBP52 determine its association with the glucocorticoid receptor, hsp90, and cytoplasmic dynein (1999) J. Biol. Chem., 274 (52), pp. 36980-36986
• Galigniana, M.D., Echeverria, P.C., Erlejman, A.G., Piwien-Pilipuk, G., Role of molecular chaperones and TPR-domain proteins in the cytoplasmic transport of steroid receptors and their passage through the nuclear pore (2010) Nucleus, 1 (4), pp. 299-308
• Gallo, L.I., Ghini, A.A., Piwien Pilipuk, G., Galigniana, M.D., Differential recruitment of tetratricorpeptide repeat domain immunophilins to the mineralocorticoid receptor influences both heat-shock protein 90-dependent retrotransport and hormone-dependent transcriptional activity (2007) Biochemistry, 46 (49), pp. 14044-14057
• Davies, T.H., Sanchez, E.R., Fkbp52 (2005) Int. J. Biochem. Cell Biol., 37 (1), pp. 42-47
• Galigniana, M.D., Erlejman, A.G., Monte, M., Gomez-Sanchez, C., Piwien-Pilipuk, G., The hsp90-FKBP52 complex links the mineralocorticoid receptor to motor proteins and persists bound to the receptor in early nuclear events (2010) Mol. Cell. Biol., 30 (5), pp. 1285-1298
• Thomas, M., Harrell, J.M., Morishima, Y., Peng, H.M., Pratt, W.B., Lieberman, A.P., Pharmacologic and genetic inhibition of hsp90-dependent trafficking reduces aggregation and promotes degradation of the expanded glutamine androgen receptor without stress protein induction (2006) Hum. Mol. Genet., 15 (11), pp. 1876-1883
• Galigniana, M.D., Harrell, J.M., O'Hagen, H.M., Ljungman, M., Pratt, W.B., Hsp90-binding immunophilins link p53 to dynein during p53 transport to the nucleus (2004) J. Biol. Chem., 279 (21), pp. 22483-22489
• Colo, G.P., Rubio, M.F., Nojek, I.M., The p160 nuclear receptor co-activator RAC3 exerts an anti-apoptotic role through a cytoplasmatic action (2008) Oncogene, 27 (17), pp. 2430-2444
• Zhao, W., Zhong, L., Wu, J., Role of cellular FKBP52 protein in intracellular trafficking of recombinant adeno-associated virus 2 vectors (2006) Virology, 353 (2), pp. 283-293
• Walker, V.E., Atanasiu, R., Lam, H., Shrier, A., Co-chaperone FKBP38 promotes HERG trafficking (2007) J. Biol. Chem., 282 (32), pp. 23509-23516
• Li, P., Ding, Y., Wu, B., Shu, C., Shen, B., Rao, Z., Structure of the N-terminal domain of human FKBP52 (2003) Acta Crystallogr. D Biol. Crystallogr., 59 (PART 1), pp. 16-22
• Vafopoulou, X., Steel, C.G., Cytoplasmic travels of the ecdysteroid receptor in target cells: Pathways for both genomic and non-genomic actions (2012) Front. Endocrinol. (Lausanne, 3, p. 43
• Galigniana, M.D., Morishima, Y., Gallay, P.A., Pratt, W.B., Cyclophilin-A is bound through its peptidylprolyl isomerase domain to the cytoplasmic dynein motor protein complex (2004) J. Biol. Chem., 279 (53), pp. 55754-55759
• Caballes, R., Cyclosporine, R.Mw., Hepatitis C, (2012) Open J. Organ Transpl. Surg., 2, pp. 32-36
• Von Hahn, T., Ciesek, S., Manns, M.P., Arrest all accessories - Inhibition of hepatitis C virus by compounds that target host factors (2011) Discov. Med., 12 (64), pp. 237-244
• Echeverria, P.C., Mazaira, G., Erlejman, A., Gomez-Sanchez, C., Piwien Pilipuk, G., Galigniana, M.D., Nuclear import of the glucocorticoid receptor-hsp90 complex through the nuclear pore complex is mediated by its interaction with Nup62 and importin beta (2009) Mol. Cell. Biol., 29 (17), pp. 4788-4797
• Galigniana, M.D., Harrell, J.M., Murphy, P.J., Binding of hsp90-associated immunophilins to cytoplasmic dynein: Direct binding and in vivo evidence that the peptidylprolyl isomerase domain is a dynein interaction domain (2002) Biochemistry, 41 (46), pp. 13602-13610
• Vermeer, H., Hendriks-Stegeman, B.I., Van Der Burg, B., Van Buul-Offers, S.C., Jansen, M., Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: A potential marker for glucocorticoid sensitivity, potency, and bioavailability (2003) J. Clin. Endocrinol. Metab., 88 (1), pp. 277-284
• Chambraud, B., Belabes, H., Fontaine-Lenoir, V., Fellous, A., Baulieu, E.E., The immunophilin FKBP52 specifically binds to tubulin and prevents microtubule formation (2007) FASEB J, 21 (11), pp. 2787-2797
• Quinta, H.R., Galigniana, N.M., Erlejman, A.G., Lagadari, M., Piwien-Pilipuk, G., Galigniana, M.D., Management of cytoskeleton architecture by molecular chaperones and immunophilins (2011) Cell Signal, 23 (12), pp. 1907-1920
• Quintá, H.R., Maschi, D., Gomez-Sanchez, C., Piwien Pilipuk, G., Galigniana, M.D., Subcellular rearrangement of hsp90-binding immunophilins accompanies neuronal differentiation and neurite outgrowth (2010) J. Neurochem., 115, pp. 716-734
• Yao, Y.L., Liang, Y.C., Huang, H.H., Yang, W.M., FKBPs in chromatin modification and cancer (2011) Curr. Opin. Pharmacol., 11 (4), pp. 301-307
• Yang, W.M., Yao, Y.L., Seto, E., The FK506- binding protein 25 functionally associates with histone deacetylases and with transcription factor YY1 (2001) EMBO J, 20 (17), pp. 4814-4825
• Ochocka, A.M., Kampanis, P., Nicol, S., FKBP25, a novel regulator of the p53 pathway, induces the degradation of MDM2 and activation of p53 (2009) FEBS Lett, 583 (4), pp. 621-626
• Gorlich, D., Kutay, U., Transport between the cell nucleus and the cytoplasm (1999) Annu. Rev. Cell Dev. Biol., 15, pp. 607-660
• Moretto-Zita, M., Jin, H., Shen, Z., Zhao, T., Briggs, S.P., Xu, Y., Phosphorylation stabilizes Nanog by promoting its interaction with Pin1 (2010) Proc. Natl Acad. Sci. USA, 107 (30), pp. 13312-13317
• Sivils, J.C., Storer, C.L., Galigniana, M.D., Cox, M.B., Regulation of steroid hormone receptor function by the 52 kDa FK506-binding protein (FKBP52 (2011) Curr. Opin. Pharmacol., 11 (4), pp. 314-319
• Stechschulte, L.A., Sanchez, E.R., FKBP51 - A selective modulator of glucocorticoid and androgen sensitivity (2011) Curr. Opin. Pharmacol., 11 (4), pp. 332-337
• Chen, H., Yong, W., Hinds Jr., T.D., Fkbp52 regulates androgen receptor transactivation activity and male urethra morphogenesis (2010) J. Biol. Chem., 285 (36), pp. 27776-27784
• Periyasamy, S., Hinds Jr., T., Shemshedini, L., Shou, W., Sanchez, E.R., FKBP51 and Cyp40 are positive regulators of androgen-dependent prostate cancer cell growth and the targets of FK506 and cyclosporin A (2010) Oncogene, 29 (11), pp. 1691-1701
• Eitoku, M., Sato, L., Senda, T., Horikoshi, M., Histone chaperones: 30 years from isolation to elucidation of the mechanisms of nucleosome assembly and disassembly (2008) Cell Mol. Life Sci., 65 (3), pp. 414-444
• Leclercq, M., Vinci, F., Galat, A., Mammalian FKBP-25 and its associated proteins (2000) Arch. Biochem. Biophys., 380 (1), pp. 20-28
• Solassol, J., Mange, A., Maudelonde, T., FKBP family proteins as promising new biomarkers for cancer (2011) Curr. Opin. Pharmacol., 11 (4), pp. 320-325
• Gallo, L.I., Lagadari, M., Piwien-Pilipuk, G., Galigniana, M.D., The 90 kDa heat-shock protein (Hsp90)-binding immunophilin FKBP51 is a mitochondrial protein that translocates to the nucleus to protect cells against oxidative stress (2011) J. Biol. Chem., 286 (34), pp. 30152-30160
• Li, L., Lou, Z., Wang, L., The role of FKBP5 in cancer aetiology and chemoresistance (2011) Br. J. Cancer, 104 (1), pp. 19-23
• Pei, H., Li, L., Fridley, B.L., FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt (2009) Cancer Cell, 16 (3), pp. 259-266
• Romano, S., D'Angelillo, A., Pacelli, R., Role of FK506-binding protein 51 in the control of apoptosis of irradiated melanoma cells (2010) Cell Death Differ, 17 (1), pp. 145-157
• Mukaide, H., Adachi, Y., Taketani, S., FKBP51 expressed by both normal epithelial cells and adenocarcinoma of colon suppresses proliferation of colorectal adenocarcinoma (2008) Cancer Invest, 26 (4), pp. 385-390
• Periyasamy, S., Warrier, M., Tillekeratne, M.P., Shou, W., Sanchez, E.R., The immunophilin ligands cyclosporin A and FK506 suppress prostate cancer cell growth by androgen receptor-dependent and -independent mechanisms (2007) Endocrinology, 148 (10), pp. 4716-4726
• Ostrow, K.L., Park, H.L., Hoque, M.O., Pharmacologic unmasking of epigenetically silenced genes in breast cancer (2009) Clin. Cancer Res., 15 (4), pp. 1184-1191
• Pearson, J.D., Mohammed, Z., Bacani, J.T., Lai, R., Ingham, R.J., The heat shock protein-90 co-chaperone, Cyclophilin 40, promotes ALK-positive, anaplastic large cell lymphoma viability and its expression is regulated by the NPM-ALK oncoprotein (2012) BMC Cancer, 12, p. 229
• Heldring, N., Pike, A., Andersson, S., Estrogen receptors: How do they signal and what are their targets (2007) Physiol. Rev., 87 (3), pp. 905-931
• Renoir, J.M., Estradiol receptors in breast cancer cells: Associated co-factors as targets for new therapeutic approaches (2012) Steroids, 77 (12), pp. 1249-1261
• Gougelet, A., Bouclier, C., Marsaud, V., Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells (2005) J. Steroid Biochem. Mol. Biol., 94 (1-3), pp. 71-81
• Meyer, B.K., Pray-Grant, M.G., Vanden Heuvel, J.P., Perdew, G.H., Hepatitis B virus X-associated protein 2 is a subunit of the unliganded aryl hydrocarbon receptor core complex and exhibits transcriptional enhancer activity (1998) Mol. Cell. Biol., 18 (2), pp. 978-988
• Cai, W., Kramarova, T.V., Berg, P., Korbonits, M., Pongratz, I., The immunophilin-like protein XAP2 is a negative regulator of estrogen signaling through interaction with estrogen receptor alpha (2011) PLoS ONE, 6 (10), pp. e25201
• De Leon, J.T., Iwai, A., Feau, C., Targeting the regulation of androgen receptor signaling by the heat shock protein 90 cochaperone FKBP52 in prostate cancer cells (2011) Proc. Natl Acad. Sci. USA, 108 (29), pp. 11878-11883
• Edlich, F., Weiwad, M., Wildemann, D., The specific FKBP38 inhibitor N-(Ń,Ń- dimethylcarboxamidomethyl)cycloheximide has potent neuroprotective and neurotrophic properties in brain ischemia (2006) J. Biol. Chem., 281 (21), pp. 14961-14970
• Gold, B.G., Armistead, D.M., Wang, M.S., Non- FK506-binding protein-12 neuroimmunophilin ligands increase neurite elongation and accelerate nerve regeneration (2005) J. Neurosci. Res., 80 (1), pp. 56-65
• Gold, B.G., Voda, J., Yu, X., Gordon, H., The immunosuppressant FK506 elicits a neuronal heat shock response and protects against acrylamide neuropathy (2004) Exp. Neurol., 187 (1), pp. 160-170
• Gold, B.G., Voda, J., Yu, X., McKeon, G., Bourdette, D.N., FK506 and a nonimmunosuppressant derivative reduce axonal and myelin damage in experimental autoimmune encephalomyelitis: Neuroimmunophilin ligand-mediated neuroprotection in a model of multiple sclerosis (2004) J. Neurosci. Res., 77 (3), pp. 367-377
• Pong, K., Zaleska, M.M., Therapeutic implications for immunophilin ligands in the treatment of neurodegenerative diseases (2003) Curr. Drug Targets CNS Neurol. Disord., 2 (6), pp. 349-356
• Gerard, M., Deleersnijder, A., Demeulemeester, J., Debyser, Z., Baekelandt, V., Unraveling the role of peptidyl-prolyl isomerases in neurodegeneration (2011) Mol. Neurobiol., 44 (1), pp. 13-27
• Quintá, H.R., Maschi, D., Gomez-Sanchez, C., Piwien-Pilipuk, G., Galigniana, M.D., Subcellular rearrangement of hsp90-binding immunophilins accompanies neuronal differentiation and neurite outgrowth (2010) J. Neurochem., 115 (3), pp. 716-734
• Sanokawa-Akakura, R., Dai, H., Akakura, S., A novel role for the immunophilin FKBP52 in copper transport (2004) J. Biol. Chem., 279 (27), pp. 27845-27848
• Zheng, W., Monnot, A.D., Regulation of brain iron and copper homeostasis by brain barrier systems: Implication in neurodegenerative diseases (2012) Pharmacol. Ther., 133 (2), pp. 177-188
• Mills, E., Dong, X.P., Wang, F., Xu, H., Mechanisms of brain iron transport: Insight into neurodegeneration and CNS disorders (2010) Future Med. Chem., 2 (1), pp. 51-64
• Chambraud, B., Sardin, E., Giustiniani, J., A role for FKBP52 in Tau protein function (2010) Proc. Natl Acad. Sci. USA, 107 (6), pp. 2658-2663
• Salminen, A., Ojala, J., Kaarniranta, K., Hiltunen, M., Soininen, H., Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease (2011) Prog. Neurobiol., 93 (1), pp. 99-110
• Jinwal, U.K., Koren III, J., Borysov, S.I., The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules (2010) J. Neurosci., 30 (2), pp. 591-599
• Islam, M.S., Transient receptor potential channels (2011) Advances in Experimental Medicine and Biology, , (1st edition). Islam MS (Ed.). Springer, NY, USA
• Parekh, A.B., Putney Jr., J.W., Store-operated calcium channels (2005) Physiol. Rev., 85 (2), pp. 757-810
• Uchino, H., Kuroda, Y., Morota, S., Probing the molecular mechanisms of neuronal degeneration: Importance of mitochondrial dysfunction and calcineurin activation (2008) J. Anesth., 22 (3), pp. 253-262
• Golstein, P., Kroemer, G., Cell death by necrosis: Towards a molecular definition (2007) Trends Biochem. Sci., 32 (1), pp. 37-43
• Bell, R.D., Winkler, E.A., Singh, I., Apolipoprotein e controls cerebrovascular integrity via cyclophilin A (2012) Nature, 485 (7399), pp. 512-516
• Tribouillard-Tanvier, D., Carroll, J.A., Moore, R.A., Striebel, J.F., Chesebro, B., Role of cyclophilin A from brains of prion-infected mice in stimulation of cytokine release by microglia and astroglia in vitro (2012) J. Biol. Chem., 287 (7), pp. 4628-4639
• Pastorino, L., Sun, A., Lu, P.J., The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production (2006) Nature, 440 (7083), pp. 528-534
• Sultana, R., Boyd-Kimball, D., Poon, H.F., Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: A redox proteomics analysis (2006) Neurobiol. Aging, 27 (7), pp. 918-925
• Ryo, A., Togo, T., Nakai, T., Prolyl-isomerase Pin1 accumulates in lewy bodies of parkinson disease and facilitates formation of alpha-synuclein inclusions (2006) J. Biol. Chem., 281 (7), pp. 4117-4125
• Kockx, M., Jessup, W., Kritharides, L., Cyclosporin A and atherosclerosis - Cellular pathways in atherogenesis (2010) Pharmacol. Ther., 128 (1), pp. 106-118
• Hackstein, H., Steinschulte, C., Fiedel, S., Sanglifehrin a blocks key dendritic cell functions in vivo and promotes long-term allograft survival together with low-dose CsA (2007) Am. J. Transplant, 7 (4), pp. 789-798
• Immecke, S.N., Baal, N., Wilhelm, J., The cyclophilin-binding agent Sanglifehrin A is a dendritic cell chemokine and migration inhibitor (2011) PLoS ONE, 6 (3), pp. e18406
• Cascone, S., Lamberti, G., Titomanlio, G., Barba, A.A., D'Amore, M., Microencapsulation effectiveness of small active molecules in biopolymer by ultrasonic atomization technique (2012) Drug Dev. Ind. Pharm., 38 (12), pp. 1486-1493
• Estebanez-Perpina, E., Arnold, L.A., Nguyen, P., A surface on the androgen receptor that allosterically regulates coactivator binding (2007) Proc. Natl Acad. Sci. USA, 104 (41), pp. 16074-16079
• Sankhala, K.K., Mita, M.M., Mita, A.C., Takimoto, C.H., Heat shock proteins: A potential anticancer target (2011) Curr. Drug Targets., 12 (14), pp. 2001-2008
• Galigniana, N.M., Ballmer, L.T., Toneatto, J., Erlejman, A.G., Lagadari, M., Galigniana, M.D., Regulation of the glucocorticoid response to stress-related disorders by the Hsp90-binding immunophilin FKBP51 (2012) J. Neurochem., 122 (1), pp. 4-18
• Touma, C., Gassen, N.C., Herrmann, L., FK506 binding protein 5 shapes stress responsiveness: Modulation of neuroendocrine reactivity and coping behavior (2011) Biol. Psychiatry, 70 (10), pp. 928-936
• Hartmann, J., Wagner, K.V., Liebl, C., The involvement of FK506-binding protein 51 (FKBP5) in the behavioral and neuroendocrine effects of chronic social defeat stress (2012) Neuropharmacology, 62 (1), pp. 332-339
• Schmidt, M.V., Paez-Pereda, M., Holsboer, F., Hausch, F., The prospect of FKBP51 as a drug target (2012) ChemMedChem, 7 (8), pp. 1351-1359
• Gopalakrishnan, R., Kozany, C., Gaali, S., Evaluation of synthetic FK506 analogues as ligands for the FK506-binding proteins 51 and 52 (2012) J. Med. Chem., 55 (9), pp. 4114-4122
• Lu, J.J., Bao, J.L., Wu, G.S., Quinones derived from plant secondary metabolites as anti-cancer agents (2012) Anticancer Agents Med. Chem., 13 (3), pp. 456-463
• Guo, C., Hou, X., Dong, L., Structure-based design of novel human Pin1 inhibitors (I (2009) Bioorg. Med. Chem. Lett., 19 (19), pp. 5613-5616
• Schiene-Fischer, C., Aumuller, T., Fischer, G., Peptide bond cis/trans isomerases: A biocatalysis perspective of conformational dynamics in proteins (2013) Top. Curr. Chem., 328, pp. 35-67

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------